Skip to main content
Year archive

CStone Pharmaceuticals — 2026 filings

All 33 regulatory filings released by CStone Pharmaceuticals (2616) in 2026, sourced directly from the official regulator.

33 Filings
2026 Period
2026 filings (33)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT - ON-MARKET SHARE REPURCHASE
Transaction in Own Shares
2026-05-13 English
VOLUNTARY ANNOUNCEMENT - CSTONE INITIATES NATIONWIDE COMMERCIAL SUPPLY OF LOCALLY MANUFACTURED PRALSETINIB CAPSULES
Regulatory Filings
2026-05-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings
2026-05-07 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025
Environmental & Social Information
2026-04-27 English
2025 ANNUAL REPORT
Annual Report FY 2025
2026-04-27 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2026-04-23 English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2026-04-22 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2026-04-22 English
VOLUNTARY ANNOUNCEMENT - ASCO 2026 PREVIEW: CSTONE TO PRESENT UPDATED CLINICAL DATA FOR CS2009 (PD 1/VEGF/CTLA 4 TRISPECIFIC ANTIBODY)
Regulatory Filings
2026-04-22 English
VOLUNTARY ANNOUNCEMENT - CSTONE PRESENTED PRECLINICAL DATA FOR THREE NOVEL OR DIFFERENTIATED ADCS AT AACR 2026, INCLUDING CS5007 (EGFR/HER3)
Regulatory Filings
2026-04-20 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change
2026-04-15 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2026
Regulatory Filings
2026-04-09 English
LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
Regulatory Filings
2026-04-02 English
LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
Regulatory Filings
2026-04-02 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025
Earnings Release FY 2025
2026-03-26 English
VOLUNTARY ANNOUNCEMENT - CSTONE UPDATED CLINICAL PROGRESS AND KEY PHASE I/II DATA FOR CS2009 (PD-1/VEGF/CTLA-4 TRISPECIFIC ANTIBODY)
Regulatory Filings
2026-03-26 English
VOLUNTARY ANNOUNCEMENT - SUGEMALIMAB RECEIVES [I, A] RECOMMENDATION IN ESMO GUIDELINE FOR CONSOLIDATION THERAPY IN PATIENTS WITH STAGE III NSCLC
Regulatory Filings
2026-03-25 English
VOLUNTARY ANNOUNCEMENT - AACR 2026 PREVIEW: CSTONE TO PRESENT PRECLINICAL DATA FOR THREE PROPRIETARY PIPELINE ASSETS
Regulatory Filings
2026-03-17 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2026
Regulatory Filings
2026-03-05 English
VOLUNTARY ANNOUNCEMENT - SUGEMALIMAB RECEIVES UK MHRA APPROVAL FOR STAGE III NSCLC
Regulatory Filings
2026-02-23 English
UPDATE ON THE QUALIFICATION OF JOINT COMPANY SECRETARY AND CHANGE OF COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVE
Board/Management Information
2026-02-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2026
Share Issue/Capital Change
2026-02-05 English
DATE OF BOARD MEETING AND NOTICE OF KEY BUSINESS UPDATES
Earnings Release FY 2025
2026-02-02 English
INSIDE INFORMATION ANNOUNCEMENT ON TRANSFER OF 100% EQUITY INTERESTS IN A WHOLLY-OWNED SUBSIDIARY THROUGH PUBLIC TENDER
M&A Activity
2026-02-01 English
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG BY 976,000 SHARES, WITH ACCUMULATED PURCHASE TOTALING 12,477,000 SHARES
Director's Dealing
2026-01-27 English
GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS
AGM Information
2026-01-23 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2026-01-21 English
CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE IN COMPOSITION OF BOARD COMMITTEES
Board/Management Information
2026-01-21 English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE FOURTH QUARTER OF 2025 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED
Regulatory Filings
2026-01-19 English
ANNOUNCEMENT ON THE MAJOR OPERATIONAL DATA FOR THE FOURTH QUARTER OF 2025
Earnings Release Q4 2025
2026-01-19 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2025
Share Issue/Capital Change
2026-01-07 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2026-01-05 English
Monthly Return
Share Issue/Capital Change
2026-01-05 English